Final overall survival results from the NICE-NEC trial (GETNE-T1913): A phase II study of nivolumab and platinum-doublet chemotherapy (CT) in untreated advanced G3 neuroendocrine neoplasms (NENs) of gastroenteropancreatic (GEP) or unknown (UK) origin

被引:16
作者
Riesco Martinez, M. C. [1 ]
Capdevila Castillon, J. [2 ]
Alonso, V. [3 ]
Jimenez-Fonseca, P. [4 ]
Teule, A. [5 ]
Grande, E. [6 ]
Sevilla, I. [7 ]
Benavent, M. [8 ]
Alonso-Gordoa, T. [9 ]
Custodio, A. [10 ]
Anton Pascual, B. [1 ]
Hernando, J. [2 ]
Polo, E. [3 ]
Castillo Trujillo, O. A. [4 ]
Garcia-Carbonero, R. [1 ]
机构
[1] UCM, Hosp Univ 12 De Octubre, Med Oncol Dept, Imas12, Madrid, Spain
[2] Vall Hebron Univ Hosp, Vall Hebron Inst Oncol VHIO, Med Oncol Dept, Barcelona, Spain
[3] Hosp Univ Miguel Servet, Inst Aragones Invest Sanitaria, Med Oncol Dept, Zaragoza, Spain
[4] Hosp Univ Cent Asturias, Med Oncol Dept, ISPA, Oviedo, Spain
[5] IDIBELL, Inst Catala Oncol ICO, Med Oncol Dept, Lhospitalet De Llobregat, Spain
[6] MD Anderson Canc Ctr Madrid, Med Oncol Dept, Madrid, Spain
[7] Hosp Univ Reg & Virgen Victoria Malaga, Invest Clin & Traslac Canc, Med Oncol Dept, Inst Invest Biomed Malaga IBIMA, Malaga, Spain
[8] Univ Hosp Virgen Rocio, Inst Biomed Sevilla IBIS, Med Oncol Dept, Seville, Spain
[9] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain
[10] Hosp Univ La Paz, Med Oncol Dept, Madrid, Spain
关键词
D O I
10.1016/j.annonc.2022.07.624
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
496MO
引用
收藏
页码:S769 / S769
页数:1
相关论文
empty
未找到相关数据